COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #87
Source   PDF   Share   Tweet
See all 143 studies
7/22
Negative
Late treatment study
Rivera et al., Cancer Discovery, doi:10.1158/2159-8290.CD-20-0941 (Peer Reviewed)
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Retrospective cancer patients, showing adjusted OR 1.03 [0.62-1.73] for HC Q. The study reports the number of HC Q+AZ patients but they do not provide results for HC Q+AZ (only HC Q + any other treatment). Significant confounding by indication and compassionate use is likely.
death, ↑2.4%, p=0.90
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit